Global Meningitis B Vaccine Production, Demand and Key Producers, 2022-2028

September 2022 | 98 pages | ID: G6F8B567B844EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Meningitis B Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Meningitis B Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meningitis B Vaccine that contribute to its increasing demand across many markets.

The global Meningitis B Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Meningitis B Vaccine total production and demand, 2017-2028, (K Units)

Global Meningitis B Vaccine total production value, 2017-2028, (USD Million)

Global Meningitis B Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Meningitis B Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)

U.S. VS China: Meningitis B Vaccine domestic production, consumption, key domestic manufacturers and share

Global Meningitis B Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)

Global Meningitis B Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global Meningitis B Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)

This reports profiles key players in the global Meningitis B Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Meningitis B Vaccine revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meningitis B Vaccine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Meningitis B Vaccine Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
Global Meningitis B Vaccine Market, Segmentation by Type
  • MenACWY (Conjugate) Vaccine
  • MenB (Recombinant Protein) Vaccine
Global Meningitis B Vaccine Market, Segmentation by Application
  • Hospital
  • Clinic
Companies Profiled:
  • GlaxoSmithKline
  • Chengdu Institute of Biological Products Co., Ltd.
  • Novartis
  • BEXSERO
  • TRUMENBA
  • Pfizer
  • Sanofi Pasteur Inc
  • Wyeth Pharmaceuticals, Inc.
Key Questions Answered

1. How big is the global Meningitis B Vaccine market?

2. What is the demand of the global Meningitis B Vaccine market?

3. What is the year over year growth of the global Meningitis B Vaccine market?

4. What is the production and production value of the global Meningitis B Vaccine market?

5. Who are the key producers in the global Meningitis B Vaccine market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Meningitis B Vaccine Introduction
1.2 World Meningitis B Vaccine Supply & Forecast
  1.2.1 World Meningitis B Vaccine Production Value (2017 & 2021 & 2028)
  1.2.2 World Meningitis B Vaccine Production (2017-2028)
  1.2.3 World Meningitis B Vaccine Pricing Trends (2017-2028)
1.3 World Meningitis B Vaccine Production by Region
  1.3.1 World Meningitis B Vaccine Production Value by Region (2017-2028)
  1.3.2 World Meningitis B Vaccine Production by Region (2017-2028)
  1.3.3 World Meningitis B Vaccine Average Price by Region (2017-2028)
  1.3.4 North America Meningitis B Vaccine Production (2017-2028)
  1.3.5 Europe Meningitis B Vaccine Production (2017-2028)
  1.3.6 China Meningitis B Vaccine Production (2017-2028)
  1.3.7 Japan Meningitis B Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Meningitis B Vaccine Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Meningitis B Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Meningitis B Vaccine Demand (2017-2028)
2.2 World Meningitis B Vaccine Consumption by Region
  2.2.1 World Meningitis B Vaccine Consumption by Region (2017-2022)
  2.2.2 World Meningitis B Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Meningitis B Vaccine Consumption (2017-2028)
2.4 China Meningitis B Vaccine Consumption (2017-2028)
2.5 Europe Meningitis B Vaccine Consumption (2017-2028)
2.6 Japan Meningitis B Vaccine Consumption (2017-2028)
2.7 South Korea Meningitis B Vaccine Consumption (2017-2028)
2.8 ASEAN Meningitis B Vaccine Consumption (2017-2028)
2.9 India Meningitis B Vaccine Consumption (2017-2028)

3 WORLD MENINGITIS B VACCINE MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Meningitis B Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Meningitis B Vaccine Production by Manufacturer (2017-2022)
3.3 World Meningitis B Vaccine Average Price by Manufacturer (2017-2022)
3.4 Meningitis B Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Meningitis B Vaccine Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Meningitis B Vaccine in 2021
  3.5.3 Global Concentration Ratios (CR8) for Meningitis B Vaccine in 2021
3.6 Meningitis B Vaccine Market: Overall Company Footprint Analysis
  3.6.1 Meningitis B Vaccine Market: Region Footprint
  3.6.2 Meningitis B Vaccine Market: Company Product Type Footprint
  3.6.3 Meningitis B Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Meningitis B Vaccine Production Value Comparison
  4.1.1 United States VS China: Meningitis B Vaccine Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Meningitis B Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Meningitis B Vaccine Production Comparison
  4.2.1 United States VS China: Meningitis B Vaccine Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Meningitis B Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Meningitis B Vaccine Consumption Comparison
  4.3.1 United States VS China: Meningitis B Vaccine Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Meningitis B Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Meningitis B Vaccine Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Meningitis B Vaccine in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Meningitis B Vaccine Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Meningitis B Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Meningitis B Vaccine Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Meningitis B Vaccine in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Meningitis B Vaccine Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Meningitis B Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Meningitis B Vaccine Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Meningitis B Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Meningitis B Vaccine Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Meningitis B Vaccine Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY TYPE

5.1 World Meningitis B Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
  5.2.1 MenACWY (Conjugate) Vaccine
  5.2.2 MenB (Recombinant Protein) Vaccine
5.3 Market Segment by Type
  5.3.1 World Meningitis B Vaccine Production by Type (2017-2028)
  5.3.2 World Meningitis B Vaccine Production Value by Type (2017-2028)
  5.3.3 World Meningitis B Vaccine Average Price by Type (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Meningitis B Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
6.3 Market Segment by Application
  6.3.1 World Meningitis B Vaccine Production by Application (2017-2028)
  6.3.2 World Meningitis B Vaccine Production Value by Application (2017-2028)
  6.3.3 World Meningitis B Vaccine Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Details
  7.1.2 GlaxoSmithKline Major Business
  7.1.3 GlaxoSmithKline Meningitis B Vaccine Product and Services
  7.1.4 GlaxoSmithKline Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 GlaxoSmithKline Recent Developments/Updates
  7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 Chengdu Institute of Biological Products Co., Ltd.
  7.2.1 Chengdu Institute of Biological Products Co., Ltd. Details
  7.2.2 Chengdu Institute of Biological Products Co., Ltd. Major Business
  7.2.3 Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Product and Services
  7.2.4 Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 Chengdu Institute of Biological Products Co., Ltd. Recent Developments/Updates
  7.2.6 Chengdu Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
7.3 Novartis
  7.3.1 Novartis Details
  7.3.2 Novartis Major Business
  7.3.3 Novartis Meningitis B Vaccine Product and Services
  7.3.4 Novartis Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.3.5 Novartis Recent Developments/Updates
  7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 BEXSERO
  7.4.1 BEXSERO Details
  7.4.2 BEXSERO Major Business
  7.4.3 BEXSERO Meningitis B Vaccine Product and Services
  7.4.4 BEXSERO Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.4.5 BEXSERO Recent Developments/Updates
  7.4.6 BEXSERO Competitive Strengths & Weaknesses
7.5 TRUMENBA
  7.5.1 TRUMENBA Details
  7.5.2 TRUMENBA Major Business
  7.5.3 TRUMENBA Meningitis B Vaccine Product and Services
  7.5.4 TRUMENBA Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.5.5 TRUMENBA Recent Developments/Updates
  7.5.6 TRUMENBA Competitive Strengths & Weaknesses
7.6 Pfizer
  7.6.1 Pfizer Details
  7.6.2 Pfizer Major Business
  7.6.3 Pfizer Meningitis B Vaccine Product and Services
  7.6.4 Pfizer Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.6.5 Pfizer Recent Developments/Updates
  7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Sanofi Pasteur Inc
  7.7.1 Sanofi Pasteur Inc Details
  7.7.2 Sanofi Pasteur Inc Major Business
  7.7.3 Sanofi Pasteur Inc Meningitis B Vaccine Product and Services
  7.7.4 Sanofi Pasteur Inc Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.7.5 Sanofi Pasteur Inc Recent Developments/Updates
  7.7.6 Sanofi Pasteur Inc Competitive Strengths & Weaknesses
7.8 Wyeth Pharmaceuticals, Inc.
  7.8.1 Wyeth Pharmaceuticals, Inc. Details
  7.8.2 Wyeth Pharmaceuticals, Inc. Major Business
  7.8.3 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product and Services
  7.8.4 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.8.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
  7.8.6 Wyeth Pharmaceuticals, Inc. Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Meningitis B Vaccine and Key Manufacturers
8.2 Meningitis B Vaccine Manufacturing Costs
8.3 Meningitis B Vaccine Production Process
8.4 Meningitis B Vaccine Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Meningitis B Vaccine Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Meningitis B Vaccine Typical Distributors
9.3 Meningitis B Vaccine Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

LIST OF TABLES

Table 1. World Meningitis B Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Meningitis B Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Meningitis B Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Meningitis B Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Meningitis B Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Meningitis B Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Meningitis B Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Meningitis B Vaccine Production Market Share by Region (2017-2022)
Table 9. World Meningitis B Vaccine Production Market Share by Region (2023-2028)
Table 10. World Meningitis B Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Meningitis B Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Meningitis B Vaccine Major Market Trends
Table 13. World Meningitis B Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Meningitis B Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Meningitis B Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Meningitis B Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Meningitis B Vaccine Producers in 2021
Table 18. World Meningitis B Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Meningitis B Vaccine Producers in 2021
Table 20. World Meningitis B Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Meningitis B Vaccine Company Evaluation Quadrant
Table 22. World Meningitis B Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Meningitis B Vaccine Production Site of Key Manufacturer
Table 24. Meningitis B Vaccine Market: Company Product Type Footprint
Table 25. Meningitis B Vaccine Market: Company Product Application Footprint
Table 26. Meningitis B Vaccine Competitive Factors
Table 27. Meningitis B Vaccine New Entrant and Capacity Expansion Plans
Table 28. Meningitis B Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Meningitis B Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Meningitis B Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Meningitis B Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Meningitis B Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Meningitis B Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Meningitis B Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Meningitis B Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Meningitis B Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Meningitis B Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Meningitis B Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Meningitis B Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Meningitis B Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Meningitis B Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Meningitis B Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Meningitis B Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Meningitis B Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Meningitis B Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Meningitis B Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Meningitis B Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Meningitis B Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Meningitis B Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Meningitis B Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Meningitis B Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Meningitis B Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Meningitis B Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Meningitis B Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Meningitis B Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Meningitis B Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Meningitis B Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Meningitis B Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Meningitis B Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Meningitis B Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Major Business
Table 63. GlaxoSmithKline Meningitis B Vaccine Product and Services
Table 64. GlaxoSmithKline Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GlaxoSmithKline Recent Developments/Updates
Table 66. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 67. Chengdu Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Chengdu Institute of Biological Products Co., Ltd. Major Business
Table 69. Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Product and Services
Table 70. Chengdu Institute of Biological Products Co., Ltd. Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Chengdu Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 72. Chengdu Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Meningitis B Vaccine Product and Services
Table 76. Novartis Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. BEXSERO Basic Information, Manufacturing Base and Competitors
Table 80. BEXSERO Major Business
Table 81. BEXSERO Meningitis B Vaccine Product and Services
Table 82. BEXSERO Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. BEXSERO Recent Developments/Updates
Table 84. BEXSERO Competitive Strengths & Weaknesses
Table 85. TRUMENBA Basic Information, Manufacturing Base and Competitors
Table 86. TRUMENBA Major Business
Table 87. TRUMENBA Meningitis B Vaccine Product and Services
Table 88. TRUMENBA Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. TRUMENBA Recent Developments/Updates
Table 90. TRUMENBA Competitive Strengths & Weaknesses
Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Major Business
Table 93. Pfizer Meningitis B Vaccine Product and Services
Table 94. Pfizer Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Pfizer Recent Developments/Updates
Table 96. Pfizer Competitive Strengths & Weaknesses
Table 97. Sanofi Pasteur Inc Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Pasteur Inc Major Business
Table 99. Sanofi Pasteur Inc Meningitis B Vaccine Product and Services
Table 100. Sanofi Pasteur Inc Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Sanofi Pasteur Inc Recent Developments/Updates
Table 102. Wyeth Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 103. Wyeth Pharmaceuticals, Inc. Major Business
Table 104. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product and Services
Table 105. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 106. Meningitis B Vaccine Raw Material
Table 107. Key Manufacturers of Meningitis B Vaccine Raw Materials
Table 108. Meningitis B Vaccine Typical Distributors
Table 109. Meningitis B Vaccine Typical Customers

LIST OF FIGURES

Figure 1. Meningitis B Vaccine Picture
Figure 2. World Meningitis B Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Meningitis B Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Meningitis B Vaccine Production (2017-2028) & (K Units)
Figure 5. World Meningitis B Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Meningitis B Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Meningitis B Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Meningitis B Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Meningitis B Vaccine Production (2017-2028) & (K Units)
Figure 10. China Meningitis B Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Meningitis B Vaccine Production (2017-2028) & (K Units)
Figure 12. Meningitis B Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Meningitis B Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Meningitis B Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Meningitis B Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Meningitis B Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Meningitis B Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Meningitis B Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Meningitis B Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Meningitis B Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Meningitis B Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Meningitis B Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Meningitis B Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Meningitis B Vaccine Markets in 2021
Figure 26. United States VS China: Meningitis B Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Meningitis B Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Meningitis B Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Meningitis B Vaccine in United States
Figure 30. Key Producers and Market Share of Meningitis B Vaccine in China
Figure 31. Key Producers and Market Share of Meningitis B Vaccine in Rest of World
Figure 32. World Meningitis B Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Meningitis B Vaccine Production Value Market Share by Type in 2021
Figure 34. MenACWY (Conjugate) Vaccine
Figure 35. MenB (Recombinant Protein) Vaccine
Figure 36. World Meningitis B Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Meningitis B Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Meningitis B Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Meningitis B Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Meningitis B Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Meningitis B Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Meningitis B Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Meningitis B Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Meningitis B Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Meningitis B Vaccine
Figure 48. Meningitis B Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Meningitis B Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source


More Publications